Has Ahsan Abdulghani, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,552 in general payments to Ahsan Abdulghani, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ahsan Abdulghani, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ahsan Abdulghani, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ahsan Abdulghani, MD

Geriatric Medicine · Turnersville, NJNPI 1881670891

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Merz North America, Inc. accounts for 91.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,324 and has fallen 97.9% since, to $49 in 2025.

$2,552in general payments, 2019–2025

Across 19 payments — averaging $134.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merz North America, Inc.$2K
Astellas Pharma US Inc$117
Revance Therapeutics, Inc.$57
Braeburn Inc.$17
Boehringer Ingelheim$16
Indivior Inc.$11

$34,520in research payments, 2019–2025

Across 5 payments — averaging $6903.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Celltrion, Inc.$33K
Adamis Pharmaceuticals Corporation$2K

What the payments were for

Food & beverage$2,44196%
Education$1104%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merz North America, Inc.	10	$2,334
Astellas Pharma US Inc	2	$117
Revance Therapeutics, Inc.	4	$57
Braeburn Inc.	1	$17
Boehringer Ingelheim	1	$16
Indivior Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$2,140

How this compares

$2,552 in reported general payments places this provider in the 85th percentile of 165 geriatric medicine providers in New Jersey.

See all geriatric medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$50,346

Medicare patients

191

Services billed

1,100

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	86	$50,759
TrulicityDulaglutide	29	$30,588
JanuviaSitagliptin Phosphate	51	$27,544
OzempicSemaglutide	18	$23,125
XareltoRivaroxaban	16	$12,198
FarxigaDapagliflozin Propanediol	19	$10,700
Atorvastatin Calcium	404	$4,135
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	14	$3,241
Lacosamide	11	$2,933
Omega-3 Acid Ethyl Esters	25	$2,778
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	15	$2,580
Tamsulosin Hcl	158	$2,463
Amlodipine Besylate	312	$2,013
Omeprazole	209	$2,009
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	13	$1,667

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Turnersville

Albert RiddleHaworth$524K
Gamil MakarClifton$82K
Joshua Shua HaimManchester$45K
Pradip ShahWest Caldwell$27K
Gregorio GuillenPerth Amboy$8K
Ketankumar VaidyaEdison$8K
Cheng-An MaoClifton$8K
Theresa RedlingLivingston$7K
Sarita RastogiHackensack$7K
Leslie FeiginDenville$7K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →